CEPH Insider Trading Activity and SEC Form 4 Filings
CEPH insider trading summary
No open-market insider purchases or sales of Cephalon Inc (CEPH) have been reported on SEC Form 4 in the past 12 months.
Latest CEPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 9, 2011 | Martyn D Greenacre | Director | Sell | $462K (5,794 @ $79.72) |
| May 9, 2011 | Martyn D Greenacre | Director | Sell | $335K (4,206 @ $79.71) |
| May 6, 2011 | William P Egan | Director | Sell | $799K (10,000 @ $79.89) |
| Dec 10, 2010 | Valli F. Baldassano | Exec. VP, Chief Compliance Off | Sell | $254K (4,000 @ $63.42) |
| Dec 8, 2010 | Frank Baldino Jr | Chairman and CEO | Sell | $9.6M (150,000 @ $64.09) |
| Mar 12, 2010 | Alain Aragues | Exec. V.P.,President of Europe | Sell | $103K (1,450 @ $70.88) |
| Mar 10, 2010 | Lesley Russell | Exec. V.P., Chief Medical Off. | Sell | $716K (10,000 @ $71.57) |
| Mar 10, 2010 | William P Egan | Director | Sell | $715K (10,000 @ $71.48) |
| Mar 8, 2010 | Jeffry L Vaught | Exec. V.P., Chief Scientific | Sell | $4.2M (59,672 @ $70.72) |
| Mar 5, 2010 | J Kevin Buchi | Chief Operating Officer | Sell | $2.1M (30,000 @ $70.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.